Press Release Nov 11 2025
Filed with NSE · · 6 pages · English
Enclosed please find press release the Company proposes to issue on unaudited consolidated financial results for the quarter ended on September 30, 2025. SANDEE P ANIL PHADNIS Sandeep Phadnis Vice President - Secretarial & Company Secretary Press Release JB Pharma records revenue growth of 8% to INR 1085 crores in Q2 FY26 # Operating EBITDA increased by 12% to INR 319 crores # Net Profit increases
JB Chemicals & Pharmaceuticals Ltd. on 6ix
In the deck
Earlier from JB Chemicals & Pharmaceuticals
- Press Release Jul 30 2025
- Press Release Jun 29 2025
- Press Release May 14 2025
- Press Release Feb 04 2025
- Press Release Nov 06 2024
Later from JB Chemicals & Pharmaceuticals
All JB Chemicals & Pharmaceuticals news releasesFollow JB Chemicals & Pharmaceuticals into a list and get an email when it puts out news.
Follow JB Chemicals & Pharmaceuticals